Study finds safer, more efficient medication for hepatitis B treatment

kavin submitted, created time 6 months 1 week (esciencenews.com)

Patients with hepatitis B who did not respond to lamivudine therapy had a better virological response after switching to entecavir for a year. Continuing the drug for an additional year led to even more clinical improvement without significant side effects, according to a new study in the July issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience (www.interscience.wiley.com). Chronic hepatitis B is the tenth leading cause of death worldwide

1 comment | Blog It | Email It | Keywords: Cancer Treatment lamividune liver diseases entecavir HBV hepatitis B hepatitis B treatment